Images List Premium Download Classic

Cholesterol

Cholesterol-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi
Univeristy Of Cincinnati
February 15, 2018 - N°20180042841

We disclose a composition comprising an echogenic liposome (elip) having an exterior surface, an interior surface, and at least one bilayer comprising at least one lipid selected from the group consisting of saturated phospholipids, unsaturated phospholipids, mixed phospholipids, and cholesterol, and a thrombolytic compound trapped by the elip. We also disclose a method of treating a medical condition in a ...
Cardiovascular disease risk assessment
Boston Heart Diagnostic Corporation
February 08, 2018 - N°20180038877

The invention provides improved methods for analyzing cardiovascular disease risk. According to the invention, an algorithm that considers ldl and hdl subfractions, along with lp(a) provides significant improvement in predicting cvd versus standard assays that include standard risk factors. Methods of the invention comprise measuring ldl and hdl subfractions in addition to lp(a) without reference to standard risk ...
Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
Sirna Therapeutics, Inc.
February 08, 2018 - N°20180037893

The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and peg-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in ...
Cholesterol Patent Pack
Download + patent application PDFs
Cholesterol Patent Applications
Download + Cholesterol-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cholesterol-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Slim and aqua concentrate having standardized and triple salt stabilized (-)-hydroxycitric acid from garcinia ...
Phytotech Extracts Private Limited
February 01, 2018 - N°20180028585

The present invention discloses a slim and aqueous extract of garcinia cambogia comprising (−)-hydroxycitric acid as dietary product for weight management. The present invention also discloses a process of preparation of aqueous extract wherein the garcinia cambogia fruit rinds are subjected to cold circulation to retain the phytochemical components and the aqueous extract is adjusted to neutral ph and ...
Heterocyclic compounds and methods of use
Medivation Technologies, Inc.
February 01, 2018 - N°20180028518

This disclosure provides compounds and methods of using those compounds to treat liver fibrosis, including liver fibrosis which is a precursor to, is concurrent with, is associated with, or is secondary to nonalcoholic steatohepatitis (nash); elevated cholesterol levels, and insulin resistance.
Methods of reducing or preventing oxidative modification of membrane polyunsaturated fatty acids
Amarin Pharmaceuticals Ireland Limited
February 01, 2018 - N°20180028480

In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing or preventing membrane cholesterol domain formation in a subject, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.
Cholesterol Patent Pack
Download + patent application PDFs
Cholesterol Patent Applications
Download + Cholesterol-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cholesterol-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Hdl-associated protein biomarker panel detection
Cleveland Heartlab, Inc.
January 25, 2018 - N°20180024152

Provided herein are methods, systems, and compositions for detecting one or more hdl-associated proteins (e. G., apoc3; apoc3 and apoa1; apoc3 and saa1/2; or proteins in biomarker panels 1-30) in a sample from a subject with, or suspected of having, cardiovascular disease (cvd) or other hdl related disease. In certain embodiments, such methods, systems, and compositions are used to determine ...
Biomarker of dementia with lewy bodies
Eisai R&d Management Co., Ltd.
January 25, 2018 - N°20180024150

Cholesterol and desmosterol levels, and the ratio of these levels can be used as a blood biomarker for alzheimer's disease, frontotemporal lobar degeneration, or dementia with lewy bodies.
Pcsk9 antibody, and pharmaceutical composition and use thereof
Ad Pharmaceutical Co., Inc.
January 25, 2018 - N°20180024131

The present invention belongs to the field of immunology and molecular biology, which relates to an anti-pcsk9 antibody, the pharmaceutical composition and method of use thereof. In particular, the present invention relates to the monoclonal antibody, which can bind pcsk9 specifically, block association of pcsk9 with ldlr, upregulate the amount of ldlr on cell surface, heighten the metabolism of ldl ...
Peptides derived from human pcsk9 catalytic domain and uses thereof for promoting ldl-r activity
Pronasci Inc.
January 25, 2018 - N°20180023071

The present invention provides compositions comprising an isolated or purified therapeutically effective hpcsk9 polypeptide derived from the hpcsk9 catalytic domain, and their use in methods of treating hypercholesterolemia.
Method of using cdcs to detect cholesterol in a sample
Boditech Med Inc.
January 18, 2018 - N°20180017587

Disclosed is a method for measuring cholesterol by using a cholesterol dependent cytolysin (cdc), which is a cholesterol binding protein, and an antibody specifically recognizing hdl-c or ldl-c. The method according to the present application is capable of rapidly measuring low density lipoproteins and high density lipoproteins at low cost, and thus can be effectively applied in various fields requiring ...
Vesicles comprising epidermal growth factor and compositions thereof
Consejo Superior De Investigaciones Científicas
January 18, 2018 - N°20180015145

The invention relates to vesicles comprising epidermal growth factor (egf), a cationic surfactant and cholesterol or derivatives thereof. The invention also discloses a procedure for their preparation, based on compressed fluid technology (cfs). The vesicles of the invention are useful in the manufacture of drugs and cosmetics and in tissue engineering.
Method of diagnosing and treating asphyxia
Infandx Ag
January 11, 2018 - N°20180011111

A method for in vitro diagnosing asphyxia and disorders related thereto, a method of in vitro estimating duration of hypoxia in a patient subjected to asphyxia, and a method for in vitro monitoring of normoxic, hypoxic and hyperoxic conditions and/or normobaric and hyperbaric oxygen therapy, includes quantitatively detecting in a biological sample of a patient a plurality of asphyxia ...
Cholesterol Patent Pack
Download + patent application PDFs
Cholesterol Patent Applications
Download + Cholesterol-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Cholesterol-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of enhancing mir-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell
Medical Diagnostic Laboratories, Llc
January 11, 2018 - N°20180010127

The present invention provides a method of quantifying mir-185 as a potential biomarker in lipid disorder or cardiovascular diseases in human. The present invention also provides a method of modulating mir-185 in regulating ldl and cholesterol metabolism in cells. The present invention has therapeutic potential in the treatment of cholesterol/ldl related cardiovascular diseases in humans.
Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4...
Warner-lambert Company Llc
January 11, 2018 - N°20180009748

Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptatonic acid hemi calcium salt designated form xx, form xxi, form xxii, form xxiii, form xxiv, form xxv, form xxvi, form xxvii, form xxviii, form xxix, and form xxx, characterized by their x-ray powder diffraction, solid-state ...
Messenger rna therapy for the treatment of ornithine transcarbamylase deficiency
Rana Therapeutics, Inc.
January 11, 2018 - N°20180008680

The present invention provides, among other things, methods of treating ornithine transcarbamylase (otc) deficiency, including administering to a subject in need of treatment a composition comprising an mrna encoding an ornithine transcarbamylase (otc) protein at an effective dose and an administration interval such that at least one symptom or feature of the otc deficiency is reduced in intensity, severity, or ...
Novel low molecular weight cationic lipids for oligonucleotide delivery
Sirna Therapeutics, Inc.
January 04, 2018 - N°20180000939

The instant invention provides for novel catiome lipids that can be used in combination with other lipid components such as cholesterol and peg-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in ...
Compositions and methods for treatment of lung disorders characterized by cholesterol dysregulation
Children's Hospital Medical Center
January 04, 2018 - N°20180000758

Disclosed are compositions and methods for treating a condition characterized by a dysregulation in macrophage lipid homeostasis. The disclosed methods may include the administration of an agent selected from a pparγ agonist, a lxr agonist, or a combination thereof. In certain aspects, the disclosed methods may be used to prevent, treat, or ameliorate conditions such as pulmonary alveolar ...
Methods for improved production of vitamins d2 and d3
Nucelis Llc
December 28, 2017 - N°20170369436

It is an object of the present invention to provide methods for producing vitamin d that gives improved yields and reduced side product contamination. In various aspects, these methods provide for production of vitamin-d2 using ergosterol as provitamin d2 or a dihydroxy derivative thereof as a starting material, or production of vitamin-d3 using 7-dehydrocholesterol as provitamin d3 or a dihydroxy ...
High density lipoprotein functionalized magnetic nanostructures
Northwestern University
December 28, 2017 - N°20170367982

Provided herein are compositions and methods for diagnosis and treatment of early-stage atherosclerotic plaques and reduction of plaques in arteries. In particular, provided herein are high-density-lipoprotein-functionalized magnetic nanostructures (hdl-mns) capable of (i) precise anatomic detection of atherosclerotic lesions, (ii) removal of excess cholesterol from macrophage cells in atherosclerotic plaque, and/or (iii) delivery of therapeutic agents to plaque locations, and ...
Cell culture media
University Of Miami
December 07, 2017 - N°20170349878

A cell culture medium comprising adenosine triphosphate; a carrier protein; cholesterol, linoleic acid, and lipoic acid; glutathione; at least one nucleotide salvage pathway precursor base; phosphoethanolamine; selenium; transferrin; triiodothyronine; all-trans-retinoic acid (atra) and vitamin c; zinc, magnesium, and copper; an agent that increases intracellular camp; epidermal growth factor (egf); hydrocortisone; insulin; and charcoal stripped fetal bovine serum, wherein said cell ...
Loading